A wellness company has announced that they have received a licence from Health Canada to cultivate Psilocybe mushrooms, commonly known as “magic mushrooms,” in their 7,000 square-foot facility.
Numinus Wellness Inc., a Vancouver-based company, says that Psilocybin-assisted psychotherapy is currently being studied as a treatment for a range of mental health conditions including depression, anxiety, and substance use disorders.
Under its Health Canada licence for the production and extraction of psilocybin from mushrooms, the company intends to develop standardized extraction methods for the mushrooms.
Numinus will also be exploring product formulations and ultimately, the delivery of safe psilocybin-assisted psychotherapy at clinics including its own.
"We are thrilled to start growing mushrooms at our laboratory under our Health Canada licence," says Michael Tan, Chief Operating Officer.
"We envision a day when the option of natural, plant-based psilocybin is available for use in therapies at Numinus Clinics and by others, and this is a tangible step towards that goal."
Numinus says they are positioned to be the first-in-market, trusted leader in the delivery of psychedelic-assisted psychotherapies, when regulated.
The laboratory is also preparing to add a contract analytical and research lab for psychedelic substances such as MDMA, psilocin, DMT, and mescaline under its Health Canada Controlled Drugs and Substances licence.
